Journal ArticleDOI
What prognostic factors are important for resected intrahepatic cholangiocarcinoma
Reads0
Chats0
TLDR
The aim was to evaluate the predictive factors for survival and disease‐free survival of patients with resected intrahepatic cholangiocarcinoma (ICC) with a focus on prognosis.Abstract:
Background and Aim: Our aim was to evaluate the predictive factors for survival and disease-free survival of patients with resected intrahepatic cholangiocarcinoma (ICC)
Methods: Between October 1994 and 2005, 97 patients with ICC underwent curative hepatic resection The tumors in 97 patients were reviewed retrospectively to examine the prognosis of ICC
Results: The 1-, 3- and 5-year survival rates were 749%, 518% and 311%, respectively The 1-, 3- and 5-year disease-free survival rates were 213%, 64% and 21%, respectively Univariate analysis showed that tumor size, tumor number, the gross type, resection margin status, T-stage and lymph node involvement were significant prognostic factors Multiple tumors and cancer cells in the resection margin were found in multivariate analysis to be significantly related to the prognosis In the multivariate analysis disease free survival was poor for the patients with a large tumor, multiple lesions, a high CA 19-9 level, cancer in the resection margin, advanced T-stage and lymph node involvement
Conclusions: The overall 5-year survival rate of ICC was 311% Multiple intrahepatic lesions were a sign of a poor prognosis for ICC Better survival could be achieved by curative resection with a tumor-free marginread more
Citations
More filters
Journal ArticleDOI
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater,Peter R. Galle,Shahid A. Khan,Josep M. Llovet,Joong-Won Park,Tushar Patel,Timothy M. Pawlik,Gregory J. Gores +7 more
TL;DR: University College, London Cancer Institute, 72 Huntley St.
Journal ArticleDOI
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
Yizhou Wang,Jun Li,Yong Xia,Renyan Gong,Kui Wang,Zhenlin Yan,Xuying Wan,Guanghua Liu,Dong Wu,Lehua Shi,Wan Yee Lau,Meng-Chao Wu,Feng Shen +12 more
TL;DR: The proposed nomogram resulted in more-accurate prognostic prediction for patients with ICC after partial hepatectomy and was superior to the five currently used staging systems on ICC.
Journal ArticleDOI
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Mechteld C. de Jong,Hari Nathan,Georgios C. Sotiropoulos,Andreas Paul,Sorin Alexandrescu,Hugo Marques,Carlo Pulitano,Eduardo Barroso,Bryan M. Clary,Luca Aldrighetti,Cristina R. Ferrone,Andrew X. Zhu,Todd W. Bauer,Dustin M. Walters,T. Clark Gamblin,Kevin Nguyen,Ryan S. Turley,Irinel Popescu,Catherine Hubert,Stephanie Meyer,Richard D. Schulick,Michael A. Choti,Jean-François Gigot,Gilles Mentha,Timothy M. Pawlik +24 more
TL;DR: Although tumor size provides no prognostic information, tumor number, vascular invasion, and LN metastasis were associated with survival and should be strongly considered for ICC.
Journal ArticleDOI
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma Systematic Review and Meta-analysis
TL;DR: The outcomes of the study were overall survival and recurrence-free survival and the prognosis of ICC is dictated mainly by tumor factors, which could focus on the usefulness of adjuvant treatment as well as other multidisciplinary treatment modalities.
Journal ArticleDOI
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.
Olivier Farges,David Fuks,Emmanuel Boleslawski,Yves-Patrice Le Treut,Denis Castaing,Alexis Laurent,Christian Ducerf,Michel Rivoire,Philippe Bachellier,Laurence Chiche,Gennaro Nuzzo,Jean-Marc Regimbeau +11 more
TL;DR: In pN0 patients, R1 resection is the strongest independent predictor of poor outcome and a margin of at least 5 mm should be created, while in patients undergoing surgery for IHCC, the survival benefits of resection in pN+ patients and R1 surgery in general are very low.
References
More filters
Journal ArticleDOI
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.
Attila Nakeeb,Henry A. Pitt,Taylor A. Sohn,Jo Ann Coleman,Ross A. Abrams,Steven Piantadosi,Ralph H. Hruban,Keith D. Lillemoe,Charles J. Yeo,John L. Cameron +9 more
TL;DR: Cholangiocarcinoma is best classified into three broad groups: 1) intrahepatic, 2) perihilar, and 3) distal tumors, which correlate with anatomic distribution and imply preferred treatment.
Journal ArticleDOI
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.
TL;DR: There has been a marked increase in the incidence and mortality from intrahepatic cholangiocarcinoma in the United States in recent years, and this tumor continues to be associated with a poor prognosis.
Journal ArticleDOI
Intrahepatic Cholangiocarcinoma: Resectability, Recurrence Pattern, and Outcomes
Sharon M. Weber,William R. Jarnagin,David S. Klimstra,Ronald P. DeMatteo,Yuman Fong,Leslie H. Blumgart +5 more
TL;DR: Although complete resection improved survival, recurrence was common and the majority of recurrences were local or regional, which may help guide future adjuvant therapy strategies.
Journal ArticleDOI
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
Masayuki Ohtsuka,Hiroshi Ito,Fumio Kimura,Hiroaki Shimizu,Akira Togawa,Hiroyuki Yoshidome,Masaru Miyazaki +6 more
TL;DR: The results of surgical treatment for intrahepatic cholangiocarcinoma (ICC) and specific factors influencing survival are still unclear.
Journal ArticleDOI
Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma.
Kazuto Inoue,Masatoshi Makuuchi,Tadatoshi Takayama,Guido Torzilli,Junji Yamamoto,Kazuaki Shimada,Tomoo Kosuge,Susumu Yamasaki,Masaru Konishi,Taira Kinoshita,Shinichi Miyagawa,Seiji Kawasaki +11 more
TL;DR: This is the first reported study on the effectiveness of liver resection for the treatment of mass-forming type cholangiocarcinoma, showing that surgical therapy can prolong survival if local radicality can be achieved and lymph-node metastases are absent.